RankingsPricing
  1. JP-listed companies
  2. EnBio Holdings,Inc
  3. Financials
  4. Total liabilities

EnBio Holdings,IncJP:6092

Market cap
¥4.8B
P/E ratio
6.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Mar 31, 202511,965+11.62%
Mar 31, 202410,719+2.16%
Mar 31, 202310,493+0.93%
Mar 31, 202210,396+0.14%
Mar 31, 202110,381+2.35%
Mar 31, 202010,143-26.24%
Mar 31, 201913,752-5.68%
Mar 31, 201814,581+53.16%
Mar 31, 20179,520+114.50%
Mar 31, 20164,438+94.50%
Mar 31, 20152,282

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)